XML 55 R40.htm IDEA: XBRL DOCUMENT v3.22.4
REVENUE, CREDIT CONCENTRATIONS AND GEOGRAPHIC INFORMATION (Tables)
12 Months Ended
Dec. 31, 2022
Risks and Uncertainties [Abstract]  
Schedule of Disaggregates of Total Net Product Revenues from External Customers by Product
The following table presents Total Revenues and disaggregates Net Product Revenues by product.
Years Ended December 31,
202220212020
Net product revenues by product:
VIMIZIM$663,739 $623,145 $544,257 
NAGLAZYME443,794 380,449 391,298 
PALYNZIQ255,032 237,474 170,983 
KUVAN227,577 285,776 457,736 
VOXZOGO169,128 5,855 — 
BRINEURA154,333 128,034 110,192 
FIRDAPSE— — 1,288 
Total net product revenues marketed by the Company1,913,603 1,660,733 1,675,754 
ALDURAZYME net product revenues marketed by Sanofi128,422 122,765 130,107 
Total net product revenues2,042,025 1,783,498 1,805,861 
Royalty and other revenues54,014 62,777 54,594 
Total revenues$2,096,039 $1,846,275 $1,860,455 
Schedule of Disaggregates of Total Net Product Revenues Based on Patient Location The table below disaggregates total Net Product Revenues by geographic region, which is based on patient location for Company's commercial products sold directly by the Company, except for ALDURAZYME, which is sold exclusively by Sanofi worldwide.
Years Ended December 31,
202220212020
United States$684,284 $657,700 $756,863 
Europe650,952 558,952 498,725 
Latin America266,801 191,151 205,862 
Rest of world311,566 252,930 214,304 
Total net product revenues marketed by the Company1,913,603 1,660,733 1,675,754 
ALDURAZYME net product revenues marketed by Sanofi128,422 122,765 130,107 
Total net product revenues$2,042,025 $1,783,498 $1,805,861 
Schedule of Total Net Product Revenue Concentrations Attributed to Largest Customers
The following table illustrates the percentage of the Company’s total Net Product Revenues attributed to the Company’s largest customers for the periods presented.
Years Ended December 31,
202220212020
Customer A16 %18 %16 %
Customer B12 %14 %15 %
Customer C%10 %12 %
Total37 %42 %43 %
Schedule of Non-Monetary Long-Lived Assets by Geographic Region
Long-lived assets, which consist of net property, plant and equipment and ROU assets are summarized by geographic region in the following table.
December 31,
20222021
Long-lived assets by geography:
United States$786,509 $763,847 
Ireland309,180 304,748 
Rest of world18,633 13,284 
Total long-lived assets$1,114,322 $1,081,879